J King, BP Deboisblanc, CM Mason, JM Onofrio, G Lipscomb, DE Mercante, WR Summer and S Nelson
Department of Medicine, Louisiana State University Medical School, New Orleans.

The effect of G-CSF pretreatment on experimental acute lung injury was studied in Sprague-Dawley rats receiving one of the following treatments: (1) G-CSF 50 micrograms/kg subcutaneously twice daily beginning 2 d prior to being killed; (2) ANTU 50 mg/kg intraperitoneally; (3) ANTU+G-CSF 50, 25, or 12.5 micrograms/kg; (4) HCl 0.6 ml of a 0.1 N solution intratracheally; (5) HCl+G-CSF 50 or 25 micrograms/kg; (6) control solutions. Lung injury was quantified by measurement of lung wet/dry weights, by histopathologic scoring, and by measurement of fluid flux during ex vivo perfusion. G-CSF pretreatment elevated the baseline blood neutrophil counts as much as 6-fold compared with Control, and it increased the numbers of lung neutrophils and caused a mild histologic lung injury, but it did not significantly alter wet/dry weight ratios or fluid flux. ANTU alone and HCl alone caused a moderate histologic lung injury, increased wet/dry weight ratio, and resulted in a small increase in flux. The combination injuries, ANTU+G-CSF and HCl+G-CSF, caused a more severe lung injury manifested by increased wet/dry weight ratios and increase in flux when compared with ANTU alone and HCl alone, respectively. We conclude that pretreatment with G-CSF potentiates ANTU- and HCl-induced lung injury in non-neutropenic rats. The potential for G-CSF to aggravate acute lung injury in patients remains speculative.

This article has been cited by other articles:

				F. J. Wiedermann, A. J. Mayr, N. C. Kaneider, D. Fuchs, N. J. Mutz, and W. Schobersberger Alveolar Granulocyte Colony-Stimulating Factor and {alpha}-Chemokines in Relation to Serum Levels, Pulmonary Neutrophilia, and Severity of Lung Injury in ARDS Chest, January 1, 2004; 125(1): 212 - 219. [Abstract] [Full Text] [PDF]

				K. Adachi, M. Suzuki, T. Sugimoto, K. Yorozu, H. Takai, K. Uetsuka, H. Nakayama, and K. Doi Effects of Granulocyte Colony-Stimulating Factor (G-CSF) on Bleomycin-Induced Lung Injury of Varying Severity Toxicol Pathol, October 1, 2003; 31(6): 665 - 673. [Abstract] [PDF]

				E. Azoulay, S. Eddahibi, E. Marcos, M. Levame, A. Harf, B. Schlemmer, S. Adnot, and C. Delclaux Granulocyte colony-stimulating factor enhances alpha-naphthylthiourea-induced pulmonary hypertension J Appl Physiol, May 1, 2003; 94(5): 2027 - 2033. [Abstract] [Full Text] [PDF]

				E. Azoulay, H. Attalah, A. Harf, B. Schlemmer, and C. Delclaux Granulocyte Colony-Stimulating Factor or Neutrophil-Induced Pulmonary Toxicity: Myth or Reality? : Systematic Review of Clinical Case Reports and Experimental Data Chest, November 1, 2001; 120(5): 1695 - 1701. [Full Text] [PDF]

				K. Yasui, K. Agematsu, A. Komiyama;, K. R. Schibler, K. A. Osborne, L. Y. Leung, T. V. Le, S. I. Baker, and D. D. Thompson Recombinant Human Granulocyte Colony-stimulating Factor Therapy for Sepsis in Infants With Neutropenia Pediatrics, June 1, 1999; 103(6): 1310 - 1310. [Full Text]

				S. Nelson A Question of Balance Am. J. Respir. Crit. Care Med., May 1, 1999; 159(5): 1365 - 1367. [Full Text] [PDF]

				B. P. Guery, S. Nelson, N. Viget, P. Fialdes, W. R. Summer, E. Dobard, G. Beaucaire, and C. M. Mason Fluorescein-labeled dextran concentration is increased in BAL fluid after ANTU-induced edema in rats J Appl Physiol, September 1, 1998; 85(3): 842 - 848. [Abstract] [Full Text] [PDF]

				H. Inano, S. Kameyama, S. Yasui, and A. Nagai Granulocyte Colony-stimulating Factor Induces Neutrophil Sequestration in Rabbit Lungs Am. J. Respir. Cell Mol. Biol., July 1, 1998; 19(1): 167 - 174. [Abstract] [Full Text]

				B. D. Freeman, Z. Quezado, F. Zeni, C. Natanson, R. L. Danner, S. Banks, M. Quezado, Y. Fitz, J. Bacher, and P. Q. Eichacker rG-CSF reduces endotoxemia and improves survival during E. coli pneumonia J Appl Physiol, November 1, 1997; 83(5): 1467 - 1475. [Abstract] [Full Text] [PDF]